BSFA BSF Enterprise Plc

LSE · GB · Healthcare · Biotechnology · bsfenterprise.com

1.125GBp0.00%Mkt Cap: 2.49M $P/E: —Today

BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing…

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$127.85BUSDP/E 29.4

MRNA

Moderna, Inc. - Common Stock

$75.86BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$75.69BUSDP/E 18.2

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

BeOne Medicines Ltd. - American Depositary Shares

$40.51BUSDP/E 63.9

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$33.03BUSDP/E 30.7

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$29.40BUSDP/E 38.3

ROIV

Roivant Sciences Ltd. - Common Shares

$25.80BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.34BUSD

INSM

Insmed Incorporated - Common Stock

$24.27BUSD

INCY

Incyte Corporation - Common Stock

Genmab A/S - American Depositary Shares

$21.69BUSDP/E 27.4

JAZZ

Jazz Pharmaceuticals plc - Ordinary Shares

$15.30BUSDP/E 16.1

ASND

Ascendis Pharma A/S - Ordinary Share

$14.99BUSDP/E 17.8

EXEL

Exelixis, Inc. - Common Stock

$14.47BUSDP/E 18.4

SMMT

Summit Therapeutics Inc. - Common Stock

$13.37BUSD

Key Statistics

Company

Market Cap2.49M USD

Enterprise Value2.35M USD

Revenue (TTM)55.51K USD

Gross Profit-19.74K USD

Net Income (TTM)-1.21M USD

Revenue/Share0.00 GBp

Last Price1.125 GBp

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees14

CountryGB

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-1.58

EV/Revenue42.42

P/S44.91

P/B0.80

EPS (TTM)-0.01

EPS (Forward)—

52W Range

0.000028% of range4.000

52W High4.000 GBp

52W Low0.0000 GBp

Profitability

Gross Margin-34.37%

Oper. Margin-5382.97%

EBITDA Margin0.00%

Profit Margin-2107.36%

ROE-40.97%

ROA-37.03%

Growth

Revenue Growth-8.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.10M USD

CapEx (TTM)11.25K USD

FCF Margin-439.92%

FCF Yield-9.80%

Net Debt784.94K USD

Net Debt/EBITDA-0.53

Balance Sheet

Debt/Equity0.00

Current Ratio0.33

Quick Ratio0.24

Book Value/Sh0.01 GBp

Cash/Share0.00 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBp

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.203.85M

Float89.28M

Insiders18.70%

Institutions0.02%

Technical

SMA 501.052 (+6.9%)

SMA 2001.463 (-23.1%)

Beta3.64

S&P 52W Chg14.58%

Avg Vol (30d)2.36M

Avg Vol (10d)2.58M

Technical Indicators

RSI (14)56.1

MACD0.0116

MACD Signal-0.0055

MACD Hist.+0.0171

BB Upper1.155 GBp

BB Middle1.026 GBp

BB Lower0.8959 GBp

BB Width25.27%

ATR (14)0.2139 GBp

Vol Ratio (20d)0.48x